Author: Chow, Ken Yan Ching; Hon, Chung Chau; Hui, Raymond Kin Hi; Wong, Raymond Tsz Yeung; Yip, Chi Wai; Zeng, Fanya; Leung, Frederick Chi Ching
Title: Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV) Document date: 2016_11_28
ID: xuj4yymz_18
Snippet: The matrix glycoprotein is not likely to be cleaved (12 ) and contains three putative transmembrane domains (12 -14 ) . Its hydrophilic domain is believed to interact with the nucleocapsid protein and is located inside the virus particle (12 ) . Linear epitope mapping of the M protein using synthetic peptides revealed that amino acid residues 2,137-2,158 interacted with SARS patient sera by ELISA assay, implying the potential capability of the M .....
Document: The matrix glycoprotein is not likely to be cleaved (12 ) and contains three putative transmembrane domains (12 -14 ) . Its hydrophilic domain is believed to interact with the nucleocapsid protein and is located inside the virus particle (12 ) . Linear epitope mapping of the M protein using synthetic peptides revealed that amino acid residues 2,137-2,158 interacted with SARS patient sera by ELISA assay, implying the potential capability of the M protein to induce immune response (34 , 35 ) .
Search related documents:
Co phrase search for related documents- amino acid and epitope mapping: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- amino acid and hydrophilic domain: 1, 2, 3, 4, 5, 6, 7, 8
- amino acid and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and matrix glycoprotein: 1, 2
- amino acid and nucleocapsid protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- amino acid and nucleocapsid protein interact: 1
- amino acid and patient sera: 1, 2, 3, 4, 5, 6
- amino acid and potential capability: 1, 2, 3
- amino acid and putative transmembrane domain: 1, 2, 3, 4, 5, 6
- amino acid and SARS patient sera: 1, 2
- amino acid and synthetic peptide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ELISA assay and epitope mapping: 1, 2, 3, 4, 5
- ELISA assay and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ELISA assay and nucleocapsid protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- ELISA assay and patient sera: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- ELISA assay and SARS patient sera: 1
- ELISA assay and synthetic peptide: 1, 2, 3, 4, 5, 6
- epitope mapping and matrix glycoprotein: 1
- epitope mapping and nucleocapsid protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date